<unk>  is a substrate of CYP1A2, CYP2C9 and CYP2C19. Inhibitors of these enzymes, e.g. the SSRI antidepressant fluvoxamine, reduce its clearance and can therefore lead to an increase in<unk>  exposure. There is also the potential for<unk>  to interact with alcohol to increase the risk of hepatotoxicity.
Agomelatine
Tropisetron
Granisetron
Alosetron
Avacopan
Cabergoline
Loteprednol
Cilansetron